Acurx Pharmaceuticals, Inc. (Nasdaq ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...
Mitochondrial DNA (mtDNA) exhibits a degree of resistance to mutagenesis under genotoxic stress, and this study on the mitochondrial Transcription Factor A (TFAM) presents valuable data concerning the ...
Artios Pharma, a Babraham-based biopharma company realising the therapeutic power of targeting the DNA damage response in ...
Funding advances Phase 2 expansion cohorts in pancreatic and colorectal cancer in ATM-negative patients for Artios’ potential ...
Artios Pharma collected $115 million from an oversubscribed series D that will support its growing ambitions for its pipeline ...
Onlymyhealth on MSN
Google's Doodle Decodes DNA: All the Facts and Science It Explains
Googles DNA Doodle explains the molecule of life Read ahead to know science surprising fun facts and memory hacks behind your ...
Artios Pharma is working on a pipeline of oncology assets, led by alnodesertib, currently being tested for second-line ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q3 2025 Earnings Call Transcript November 12, 2025 Acurx Pharmaceuticals, Inc.
Today’s Google Doodle for the India region shows the base of generic codes - DNA or Deoxyribonucleic Acid. On the purpose of ...
Artios Pharma, which looking for newer targets that, like PARP inhibitors, affect the way tumors fix themselves, said its ...
The Oak Ridger on MSN
Can microbes thrive under industrial conditions to make biofuel?
Scientists are genetically engineering microbes to withstand industrial conditions for biofuel production. Researchers found that partially suppressing genes in cyanobacteria improved their growth ...
Artificial intelligence (AI) is set to transform the care of women with cancer. From early detection via digital phenotyping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback